Santa Cruz Biotechnology features a diverse variety of VacA Antibodies for research focused on understanding VacA protein functions. VacA Antibodies are available for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). VacA protein, produced by Helicobacter pylori, induces vacuolation in host cells and plays a significant role in the pathogenesis of gastric diseases, including peptic ulcers and gastric cancer. Understanding VacA mechanisms is crucial for developing therapeutic strategies against H. pylori infections and related gastrointestinal disorders. Research on VacA provides valuable insights into host-pathogen interactions and immune responses. Scientists investigating VacA can explore its role in bacterial pathogenesis, cell signaling pathways, and inflammatory processes. Ongoing research continues to reveal new aspects of VacA's involvement in disease progression and potential therapeutic targets. VacA monoclonal antibodies from Santa Cruz Biotechnology enable researchers worldwide to advance scientific understanding of bacterial pathogenesis and contribute to the development of new therapeutic strategies.